Sign in

CIK 0001824293 · <br>Emerging growth company

GRI Bio, Inc.

Sign in to watch
Ticker
GRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
824369909
Phone
(619) 400-1171
Business address
2223 AVENIDA DE LA PLAYA, SUITE 208, LA JOLLA, CA, 92037
Former names
Vallon Pharmaceuticals, Inc.
  1. 8-K Event Results of operations
  2. 10-K Report Annual Report
  3. 8-K Event Other events
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations · Other events
  6. 8-K Event Other events
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 4 Open-market buy Chief Financial Officer bought 6,250 shares at an average $4.03 ($25,175)
  10. 4 Open-market buy Director bought 17,500 shares at an average $4.10 ($71,795)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations · Executive or director change
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 18 of 21 · 403 filings